Trials / Conditions / Anemia in Myelodysplastic Syndromes
Anemia in Myelodysplastic Syndromes
3 registered clinical trials studyying Anemia in Myelodysplastic Syndromes.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia NCT07052006 | Halia Therapeutics, Inc. | Phase 2 |
| Terminated | A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS NCT04623996 | Sumitomo Pharma America, Inc. | Phase 1 / Phase 2 |
| Unknown | Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic NCT00437450 | Groupe Francophone des Myelodysplasies | Phase 2 |